Real Estate
Home›Real Estate›Industry›GLP-1 weight-loss drugs are shifting consumer spending…
GLP-1 weight-loss drugs are shifting consumer spending toward wellness
A study cited by Commercial Observer found GLP-1 users cut fast-food and coffee spending by 8 percent, while sweets spending fell by up to 10 percent.
Commercial Observer says the spread of weight-loss drugs in the GLP-1 class is starting to show up in retail spending patterns, with effects that could ripple into real estate demand for different kinds of neighborhood businesses. The outlet points to a study suggesting people on GLP-1s reduced their spending at fast-food joints and coffee shops by 8 percent, and cut spending on sweets by as much as 10 percent.
The story links those changes to pressure on certain limited-service restaurant brands. Commercial Observer notes J.M. Smucker, maker of Hostess snacks, has had six straight quarters of decline, and it cites restaurant filings for bankruptcy over the past two years, alongside closures at chains including Wendy’s, Jack in the Box, Denny’s, Outback Steakhouse, Red Robin, and Pizza Hut.
At the same time, the outlet says wellness-oriented categories appear to be gaining traction. It cites Placer.ai for finding organic and healthy markets have seen steady increases since 2022, and it reports that gyms are getting traffic beyond the typical early-year surge.
Commercial Observer also includes industry commentary suggesting the gym membership churn that often follows New Year is easing. It quotes Placer.ai’s head of analytical research, R.J. Hottovy, saying that publicly reported chain data indicate membership attrition has flattened, with gyms still losing members but at a smaller pace than in the past.
Latest closeCoffee $314.20 ▲1.6%